Cargando…

Early mobilization on continuous renal replacement therapy is safe and may improve filter life

Detalles Bibliográficos
Autor principal:	Jacobs, Frederic M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411787/ https://www.ncbi.nlm.nih.gov/pubmed/25927350 http://dx.doi.org/10.1186/s13054-015-0781-4

Ejemplares similares

Early mobilization on continuous renal replacement therapy is safe and may improve filter life
por: Wang, Yi Tian, et al.
Publicado: (2014)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Filter clotting with continuous renal replacement therapy in COVID-19
por: Endres, Paul, et al.
Publicado: (2020)

Filter Clotting with Continuous Renal Replacement Therapy in COVID-19
por: Rosovsky, Rachel P., et al.
Publicado: (2020)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Distinction between induction and maintenance dosing in continuous renal replacement therapy
por: MacLaren, Graeme
Publicado: (2011)

Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
por: Dickie, Helen, et al.
Publicado: (2015)

Endocan is a reliable biomarker during continuous renal replacement therapy
por: Hureau, Maxence, et al.
Publicado: (2019)

Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

Early versus late renal replacement therapy in acute kidney injury: the search for a definition of timing continues
por: Bannard-Smith, Jonathan, et al.
Publicado: (2011)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
por: Honore, Patrick M., et al.
Publicado: (2015)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
por: Aguilar, Gerardo, et al.
Publicado: (2020)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

β-lactam antibiotic concentrations during continuous renal replacement therapy
por: Beumier, Marjorie, et al.
Publicado: (2014)

Comparison of adsorption of selected antibiotics on the filters in continuous renal replacement therapy circuits: in vitro studies
por: Onichimowski, Dariusz, et al.
Publicado: (2019)

Too early initiation of renal replacement therapy may be harmful
por: Vinsonneau, Christophe, et al.
Publicado: (2011)

Walking While Dialyzing: A Retrospective Observation of Early Mobility and Ambulation for Patients on Continuous Renal Replacement Therapy
por: Bento, Haley A., et al.
Publicado: (2020)

Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis
por: Brain, Matthew, et al.
Publicado: (2017)

Mathematical modelling of post-filter ionized calcium during citrate anticoagulated continuous renal replacement therapy
por: Forsal, Innas, et al.
Publicado: (2021)

Variation of High-Sensitivity Troponin T Results in Patients Undergoing Continuous Renal Replacement Therapy
por: Srinivasan Sridhar, Vikas, et al.
Publicado: (2019)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Renal replacement therapy in severe COVID-19 patients: Intermittent or continuous, the ongoing debate
por: Gaudray, Eliott, et al.
Publicado: (2021)

Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis
por: Wang, Guizhong, et al.
Publicado: (2023)

Filter life span in postoperative cardiovascular surgery patients requiring continuous renal replacement therapy, using a postdilution regional citrate anticoagulation continuous hemofiltration circuit
por: Kośka, Agnieszka, et al.
Publicado: (2022)

Continuous renal replacement therapy in COVID-19—associated AKI: adding heparin to citrate to extend filter life—a retrospective cohort study
por: Valle, Eduardo de Oliveira, et al.
Publicado: (2021)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j06v9a2mqfm3uge9nsgrihjnep